Ellie Hershberger, PharmD
Chief Development Officer
Dr. Ellie Hershberger brings more than 25 years of drug development experience across the life sciences industry, including extensive work in infectious diseases, to Peptilogics. In her role as chief development officer, she oversees the strategic, scientific, and operational execution of the company’s development programs. Dr. Hershberger’s background spans executive roles in R&D, clinical development, and portfolio management. Throughout her career, she has contributed to multiple successful global product launches and has guided programs from discovery through life‑cycle management.